Acumen Pharmaceuticals Inc (ABOS)
2.31
-0.06
(-2.53%)
USD |
NASDAQ |
Nov 21, 16:00
2.305
0.00 (0.00%)
Pre-Market: 20:00
Acumen Pharmaceuticals Shareholders Equity (Quarterly): 217.20M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 217.20M |
| June 30, 2024 | 243.95M |
| March 31, 2024 | 262.03M |
| December 31, 2023 | 266.97M |
| September 30, 2023 | 280.27M |
| June 30, 2023 | 168.87M |
| March 31, 2023 | 179.08M |
| December 31, 2022 | 188.78M |
| Date | Value |
|---|---|
| September 30, 2022 | 196.65M |
| June 30, 2022 | 206.52M |
| March 31, 2022 | 216.09M |
| December 31, 2021 | 225.18M |
| September 30, 2021 | 233.36M |
| June 30, 2021 | -106.08M |
| March 31, 2021 | -45.46M |
| December 31, 2020 | -18.59M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-106.08M
Minimum
Jun 2021
280.27M
Maximum
Sep 2023
169.68M
Average
211.30M
Median
Shareholders Equity (Quarterly) Benchmarks
| Kodiak Sciences Inc | 185.37M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 266.98M |
| Total Liabilities (Quarterly) | 49.77M |